Skip to main content
logo
Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.670
+0.220 (4.94%)
At close: Aug 21, 2026, 4:00 PM EDT
4.790
+0.120 (2.57%)
After-hours: Aug 21, 2026, 5:16 PM EDT

Alterity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
766014112244
Market Cap Growth
71.29%327.48%23.14%-47.27%-50.72%259.32%
Enterprise Value
41576-5-417
Last Close Price
4.674.091.812.796.1113.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
17.2616.785.224.366.1113.45
PB Ratio
2.112.151.520.750.881.92
P/TBV Ratio
2.112.151.520.750.881.92

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
9.3115.972.22--5.37

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.000.000.010.010.000.00
Net Debt / Equity Ratio
-0.90-0.95-0.90-0.68-0.98-0.92
Net Debt / EBITDA Ratio
2.802.770.641.072.241.85
Net Debt / FCF Ratio
3.583.540.990.782.791.62
Asset Turnover
0.200.170.170.110.140.20
Quick Ratio
21.6812.623.105.586.7910.56
Current Ratio
21.9812.983.546.177.0710.92
Return on Equity (ROE)
-47.02%-43.23%-104.47%-47.38%-38.97%-81.39%
Return on Assets (ROA)
-32.54%-28.09%-52.66%-26.64%-25.85%-43.62%
Return on Capital Employed (ROCE)
-32.30%-34.50%-141.60%-63.80%-43.60%-49.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-12.74%-13.31%-91.15%-80.84%-41.06%-26.24%
FCF Yield
-12.87%-12.55%-60.11%-117.35%-39.72%-29.72%
Buyback Yield / Dilution
-74.72%-75.31%-50.29%-0.91%-41.79%-89.62%
SEC Filings: 10-K · 10-Q